Double Blind

Maurie Markman blind-ranked landmark gynecologic oncology trials, names his Mount Rushmore of gynecologic oncology, talked about being mentored by Stephen B. Howell, MD, and explained why intraperitoneal chemotherapy was abandoned for the wrong reasons.